Eli Lilly and Company: Insulin Resistance trials
The registry lists 10 Insulin Resistance studies with Eli Lilly and Company as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 3Phase 3 1Phase 4 4No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
- Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesCompletedNCT01175824Phase 4Results posted
- A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusCompletedNCT01175811Phase 4Results posted
- Bioequivalence of Two Lispro FormulationsCompletedNCT01133392Phase 1Results posted
- A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes MellitusActive, not recruitingNCT06982859Phase 1
- A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes MellitusCompletedNCT06362265Phase 1
- Observational Study in Japanese Type 2 Diabetes PatientsCompletedNCT01055808
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCompletedNCT00551538Phase 4
- Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNCT00551356Phase 3